Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era. (Q38609576)

4 September 2017

title

Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era. (English)

1 reference

4 September 2017

main subject

anti-retroviral agent

0 references

1 reference

Cristina Brickman

1 reference

4 September 2017

Joel M Palefsky

series ordinal

1 reference

4 September 2017

publication date

16 October 2015

1 reference

4 September 2017

published in

Current HIV/AIDS reports

1 reference

4 September 2017

1 reference

4 September 2017

1 reference

4 September 2017

page(s)

388-396

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

4 September 2017

1 reference

Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Moving forward in HIV-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV infection and the risk of cancers with and without a known infectious cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer Burden in the HIV-Infected Population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV infection, immunodeficiency, viral replication, and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

The evolution of the population-based cancer registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Non-AIDS-defining cancers among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer risk in people infected with human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer burden among HIV-positive persons in Nigeria: preliminary findings from the Nigerian AIDS-cancer match study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

The increasing burden of HIV-associated malignancies in resource-limited regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

The spectrum of cancers in West Africa: associations with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV infection is associated with an increased risk for lung cancer, independent of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Elevated incidence of lung cancer among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Lung cancer incidence and survival among HIV-infected and uninfected women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancers attributable to infections among adults with HIV in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Viral hepatitis and HIV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Sexual transmission and the natural history of human herpesvirus 8 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Hodgkin's disease and the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Functions of Tat: the versatile protein of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV infection, aging, and immune function: implications for cancer risk and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV and inflammation: mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Loss of mucosal CD4 lymphocytes is an early feature of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Markers of microbial translocation and risk of AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Circulating inflammation markers and prospective risk for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Age at Cancer Diagnosis Among Persons With AIDS in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Cancer treatment disparities in HIV-infected individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Reduced lung-cancer mortality with low-dose computed tomographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

Challenges in the detection, prevention, and treatment of HIV-associated malignancies in low- and middle-income countries in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-015-0283-7

HIV-1 Tat enhances replicative potential of human oral keratinocytes harboring HPV-16 genome.

21 January 2018

1 reference

12 December 2020

Spectrum of HIV/AIDS related cancers in India

1 reference

12 December 2020

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study

1 reference

12 December 2020

HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases

1 reference

12 December 2020

Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California

1 reference

12 December 2020

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003

1 reference

12 December 2020

Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse

1 reference

12 December 2020

Impact of HIV on lung tumorigenesis in an animal model

1 reference

12 December 2020

Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States

1 reference

12 December 2020

Impact of the expanded AIDS surveillance case definition on AIDS case reporting--United States, first quarter, 1993

1 reference

12 December 2020

Prevalence of undiagnosed HIV infection among persons aged ≥13 years--National HIV Surveillance System, United States, 2005-2008.

1 reference

12 December 2020

10.1007/S11904-015-0283-7

Identifiers

DOI

1 reference

4 September 2017

1 reference